Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadin in Idiopathic REM Sleep Behavior Disorder
NCT02836743Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in REM sleep behavior disorder (RBD) (3 arms), sponsored by Seoul National University Hospital. Primary endpoints: Clinical Global Impression at 4 weeks and RBD Questionnaire-Hong Kong at 4 weeks. Status: unknown.
02
Drugs
melatonin
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT02836743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836743.